文献速递主动脉外科瓣膜外科

择期保留瓣膜主动脉根部置换中半弓置换的获益与必要性再评估

Revisiting ascending aortic resection in the elective valve-sparing root replacement: assessing the benefits and necessity of hemiarch replacement at three centres†.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

该多中心回顾性研究纳入986例择期保留瓣膜主动脉根部置换(VSRR)患者,41%同期行半弓置换。倾向评分匹配后,两组10年复合终点无显著差异(87.3% vs 85.0%,P>0.999),但二叶主动脉瓣患者半弓组干预率显著更高(10.8% vs 0%,P=0.016)。

要点

  • 择期VSRR同期半弓置换不增加围术期风险,但中远期未减少主动脉再干预。
  • 二叶主动脉瓣患者半弓置换组干预率显著高于未半弓组(10.8% vs 0%,P=0.016)。
  • 仅远端升主动脉直径>45 mm时半弓置换有获益趋势,其他形态学指标无可靠切点。

核心结论

  • 择期VSRR同期半弓置换不增加年轻患者围术期风险,但中远期随访未显示可保护免于主动脉再干预。

研究设计与样本

  • 三中心回顾性研究,纳入986例择期VSRR患者,排除年龄<18岁、Stanford A型夹层、弓部夹层及全弓置换或既往弓部置换者,行1:1倾向评分匹配。

主要发现

  • 401例(41%)行半弓置换,585例(59%)未行;根部表型565例(57%);平均随访4.7年(SD±4.6)。
  • 匹配人群中,非半弓组与半弓组10年免于复合终点无显著差异(87.3% vs 85.0%,P>0.999)。
  • 主动脉再干预(P=0.13)与生存(P=0.5)亦无差异,遗传性胸主动脉疾病患者同样如此。
  • 二叶主动脉瓣患者中半弓组干预率显著更高(10.8% vs 0%,P=0.016)。
  • 两组30天脑血管事件发生率无显著差异(非半弓组5% vs 半弓组2.7%,P=0.117)。

关键数值与推荐

  • 仅远端升主动脉直径>45 mm显示半弓置换有更好结局的趋势;基于升主动脉长度、直径身高指数或长度身高指数未发现可靠切点。

临床怎么用

  • 择期VSRR中半弓置换可安全实施,但不应期望其降低中远期主动脉再干预风险。
  • 二叶主动脉瓣患者行半弓置换需谨慎权衡,因该组再干预率反而更高。
  • 远端升主动脉直径>45 mm可能是考虑半弓置换的参考指标,但证据有限。

局限性

  • 回顾性研究设计,存在选择偏倚可能;随访时间中等(平均4.7年),远期结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to determine the indication and optimal timing for performing a hemiarch procedure in patients undergoing valve-sparing root replacement (VSRR). METHODS: We conducted a retrospective study on 986 patients undergoing VSRR at three tertiary care centres. Inclusion criteria were all patients undergoing elective VSRR. Exclusion criteria were age <18 years, Stanford type A dissection, dissection in the arch, total aortic arch replacement or previous aortic arch replacement. We performed propensity score matching in a 1:1 ratio. The primary end-point is a composite outcome that includes mortality, aortic arch reintervention, new aortic dissection during follow-up and cerebrovascular incidents within the first 30 days. RESULTS: A total of 401 patients (41%) had a hemiarch replacement, while 585 (59%) did not. Root phenotype was present in 565 (57%). The mean follow-up time was 4.7 years (SD ± 4.6). In the matched population, there was no significant difference in the 10-year freedom from the composite outcome between the non-hemiarch and hemiarch groups (87.3% vs 85.0%, P > 0.999). Similarly, no difference was found for aortic reinterventions (P = 0.13) or survival (P = 0.5). This was also true for patients with heritable thoracic aortic disease. However, in patients with a bicuspid aortic valve, the intervention rate was significantly higher in the hemiarch group (10.8% vs 0%, P = 0.016). There was no significant difference in the 30-day incidence of cerebrovascular accidents between the groups (5% vs 2.7% in the hemiarch group, P = 0.117). Only the distal ascending diameter showed a tendency with better outcome over 45 mm for the hemiarch procedure; otherwise, we found no reliable cut-off values based on ascending length, diameter-to-height index or ascending length-to-height index. CONCLUSIONS: Our findings conclusively demonstrate that concomitant hemiarch replacement does not increase the perioperative risk in young patients undergoing VSRR. However, concomitant replacement does not seem to protect from aortic reinterventions during medium-term follow-up.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Yildiz M, Schoenhoff F, Werdecker V, et al. Revisiting ascending aortic resection in the elective valve-sparing root replacement: assessing the benefits and necessity of hemiarch replacement at three centres†. Eur J Cardiothorac Surg. 2025. PMID: 39832263. doi:10.1093/ejcts/ezaf006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。